This site may require a log-in in the near future. We are constantly being swamped by AI agents. If they continue to take down the site, we will be changing to requiring logins to access any item.

🍽️ hymecromone,(prescription)

AI Engines For more Details: Perplexity  Kagi Labs  You 

  1. Gallstones:

    • Hymecromone is commonly used in the treatment of gallstones, particularly in patients with cholesterol gallstones.
    • It works by increasing the solubility of cholesterol in bile and reducing the secretion of cholesterol by the liver, thereby helping to prevent the formation of new gallstones and facilitating the dissolution of existing ones.

  2. Biliary Disorders:

    • In addition to gallstones, hymecromone may be prescribed for other biliary disorders such as biliary dyskinesia and biliary colic.
    • It helps to improve the flow of bile from the liver and gallbladder, which can relieve symptoms like abdominal pain, bloating, and discomfort associated with these conditions.

  3. Liver Disorders:

    • Hymecromone has been studied for its potential hepatoprotective effects and its ability to improve liver function in conditions such as hepatitis and liver cirrhosis.
    • By promoting bile flow and reducing inflammation in the liver, hymecromone may help to alleviate symptoms and improve liver enzyme levels in certain liver diseases.

  4. Smooth Muscle Disorders:

    • Hymecromone's spasmolytic properties make it useful in the treatment of smooth muscle disorders, such as spastic colitis and irritable bowel syndrome (IBS).
    • It helps to relax smooth muscle in the gastrointestinal tract, reducing symptoms like abdominal cramps, spasms, and discomfort.

  5. Other Uses:

    • Hymecromone may also have other potential therapeutic effects, including anti-inflammatory and antioxidant properties, although further research is needed to fully understand these effects.
    • Some studies suggest that hymecromone may have beneficial effects in conditions such as osteoarthritis and autoimmune diseases, although its use for these purposes is less well-established.
;

Check for interactions on Supp.AI   |   📚 PubMed Citations

⚗️ Compensation for antibiotic usage

Data Contradictions — Limits of Certainity

Impacted of hymecromone,(prescription) On Probiotics

Rank Probiotic Impact

Bacteria Impacted by hymecromone,(prescription)

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

🧙?

📓 Direct Citations 👪👶 Indirect Citations Taxonomy Rank Effect
0 1 Bacteroides genus Decreases
0 1 Streptococcus genus Decreases
0 1 Agathobacter genus Decreases
0 1 Thomasclavelia genus Decreases
1 0 Bacteroides xylanisolvens species Decreases
1 0 Streptococcus parasanguinis species Decreases
1 0 Agathobacter rectalis species Decreases
0 1 Streptococcus sp. HSISM1 species Decreases
0 1 Streptococcus sp. LPB0220 species Decreases
0 1 Bacteroides luhongzhouii species Decreases
0 1 Bacteroides sp. DH3716P species Decreases
0 1 Bacteroides faecium species Decreases
0 1 Streptococcus lactarius species Decreases
0 1 Streptococcus gordonii species Decreases
0 1 Bacteroides caecimuris species Decreases
0 1 Streptococcus salivarius species Decreases
1 0 Thomasclavelia ramosa species Decreases
1 0 Bacteroides thetaiotaomicron species Decreases

Impact of hymecromone,(prescription) on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
Abdominal Aortic Aneurysm 0.1 0.1
ADHD 0.3 0.3
Allergic Rhinitis (Hay Fever) 0.4 0.5 -0.25
Allergies 0.2 -0.2
Allergy to milk products 0.2 0.2 0
Alzheimer's disease 0.2 0.8 -3
Ankylosing spondylitis 0.4 0.2 1
Anorexia Nervosa 0.2 0.5 -1.5
Antiphospholipid syndrome (APS) 0.2 0.2
Asthma 0.5 0.4 0.25
Atherosclerosis 0.2 0.2
Atrial fibrillation 0.5 0.5 0
Autism 0.4 0.7 -0.75
Autoimmune Disease 0.2 0.2
Barrett esophagus cancer 0.2 -0.2
benign prostatic hyperplasia 0.2 -0.2
Biofilm 0.5 0.5
Bipolar Disorder 0.2 0.2
Brain Trauma 0.2 0.2 0
Carcinoma 0.4 0.2 1
Celiac Disease 0.4 0.2 1
Cerebral Palsy 0.4 0.2 1
Chronic Fatigue Syndrome 0.4 0.7 -0.75
Chronic Kidney Disease 0.2 0.3 -0.5
Chronic Lyme 0.2 -0.2
Chronic Obstructive Pulmonary Disease (COPD) 0.6 0.2 2
Chronic Urticaria (Hives) 0.2 0.2
Coagulation / Micro clot triggering bacteria 0.2 0.2 0
Cognitive Function 0.4 0.2 1
Colorectal Cancer 0.8 0.3 1.67
Constipation 0.2 0.2
Coronary artery disease 0.3 0.5 -0.67
COVID-19 0.5 1.1 -1.2
Crohn's Disease 0.4 0.5 -0.25
Cushing's Syndrome (hypercortisolism) 0.2 -0.2
cystic fibrosis 0.2 -0.2
deep vein thrombosis 0.4 -0.4
Denture Wearers Oral Shifts 0.3 0.3
Depression 0.7 0.8 -0.14
Dermatomyositis 0.2 0.2
Eczema 0.2 0.3 -0.5
Endometriosis 0.4 0.4
Eosinophilic Esophagitis 0.2 -0.2
Epilepsy 0.4 0.2 1
erectile dysfunction 0.2 0.2
Fibromyalgia 0.1 0.2 -1
Functional constipation / chronic idiopathic constipation 0.4 0.2 1
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus 0.2 -0.2
Generalized anxiety disorder 0.4 0.4 0
Glioblastoma 0.2 -0.2
Gout 1 1
Graves' disease 0.2 0.4 -1
Gulf War Syndrome 0.2 0.1 1
Halitosis 0.4 0.2 1
Hashimoto's thyroiditis 0.2 0.2 0
Heart Failure 0.4 0.3 0.33
Hidradenitis Suppurativa 0.4 0.4
hyperglycemia 0.2 0.2 0
hypertension (High Blood Pressure 0.4 0.4 0
Hypoxia 0.2 0.2
IgA nephropathy (IgAN) 0.4 0.1 3
Inflammatory Bowel Disease 0.6 0.8 -0.33
Insomnia 0.5 0.6 -0.2
Intelligence 0.2 0.2
Intracranial aneurysms 0.2 0.2
Irritable Bowel Syndrome 0.4 0.4 0
ischemic stroke 0.4 0.3 0.33
Liver Cirrhosis 0.6 0.4 0.5
Long COVID 0.7 0.4 0.75
Mast Cell Issues / mastitis 0.2 0.2
ME/CFS with IBS 0.2 0.2 0
ME/CFS without IBS 0.2 0.2 0
membranous nephropathy 0.2 0.2
Menopause 0.2 0.2
Metabolic Syndrome 0.4 0.4 0
Mood Disorders 0.7 0.8 -0.14
multiple chemical sensitivity [MCS] 0.3 0.3
Multiple Sclerosis 0.6 0.7 -0.17
Multiple system atrophy (MSA) 0.3 0.3
myasthenia gravis 0.2 0.2
neuropathic pain 0.2 -0.2
Neuropathy (all types) 0.2 0.2
neuropsychiatric disorders (PANDAS, PANS) 0.2 0.2
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 0.5 0.5 0
NonCeliac Gluten Sensitivity 0.2 0.2 0
Obesity 0.4 0.5 -0.25
obsessive-compulsive disorder 0.4 0.5 -0.25
Osteoarthritis 0.5 0.4 0.25
Osteoporosis 0.2 0.4 -1
pancreatic cancer 0.2 0.2 0
Parkinson's Disease 0.5 0.9 -0.8
Polycystic ovary syndrome 0.4 0.4 0
primary biliary cholangitis 0.2 0.2 0
Primary sclerosing cholangitis 0.7 0.7
Psoriasis 0.2 0.5 -1.5
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 0.4 0.5 -0.25
Schizophrenia 0.4 0.2 1
Sjögren syndrome 0.2 0.3 -0.5
Sleep Apnea 0.2 -0.2
Slow gastric motility / Gastroparesis 0.2 0.2
Small Intestinal Bacterial Overgrowth (SIBO) 0.4 0.4
Stress / posttraumatic stress disorder 0.2 0.2 0
Systemic Lupus Erythematosus 0.4 0.4
Tic Disorder 0.2 0.2
Tourette syndrome 0.2 0.2 0
Type 1 Diabetes 0.4 0.4 0
Type 2 Diabetes 0.5 0.4 0.25
Ulcerative colitis 0.5 0.3 0.67
Unhealthy Ageing 0.4 0.3 0.33
Vitiligo 0.4 0.4

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.   Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA   Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.   Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.   Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]